ACLY and prostate cancer: This has been reported in prostate cancer cells, which could be inhibited only by C75 and SB204990, inhibitors of FASN and ACLY, respectively, in the absence of lipoprotein, the transporter of exogenous fatty acid and cholesterol [61].